DNA Rewriting
DNA rewriting refers to emerging gene-editing technologies that build upon and extend the capabilities of CRISPR systems. While CRISPR revolutionized gene editing by enabling precise cuts to DNA sequences, successor technologies aim to expand the range of editable mutations and improve accuracy and efficiency. These advances represent the next generation of molecular tools for modifying genetic material in living organisms.
Beyond Base Editing and Prime Editing
Researchers at institutions including the Broad Institute, led by Dr. Feng Zhang, have developed technologies that go beyond CRISPR’s basic approach. Prime editing, for example, allows scientists to make targeted insertions, deletions, and corrections without creating double-strand breaks in DNA, potentially reducing off-target effects. Other emerging approaches include base editors that convert one DNA nucleotide directly into another, and more recently developed systems that can rewrite larger stretches of genetic code.
Applications and Future Development
DNA rewriting technologies are being explored for potential therapeutic applications in genetic diseases, viral infections, and certain cancers. The improved precision and versatility of these systems compared to earlier gene-editing methods may enable treatment of a broader spectrum of genetic conditions. However, these technologies remain largely in research and early development phases, with significant work needed to translate laboratory advances into clinical treatments.